Dyne Therapeutics, Inc.
DYN
$18.29
-$0.37-1.98%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -3.62% | 2.54% | 3.90% | -28.83% | 7.81% |
| Total Depreciation and Amortization | -0.38% | 3.98% | 0.20% | 11.56% | 2.74% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 0.40% | 8.58% | -20.35% | 27.70% | 24.91% |
| Change in Net Operating Assets | -292.76% | 4.02% | 256.61% | 29.16% | -135.86% |
| Cash from Operations | -23.19% | 4.14% | 10.57% | -25.56% | -13.01% |
| Capital Expenditure | 97.48% | -31,875.00% | 93.88% | 8.74% | -324.90% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 107.81% | -374.80% | 180.20% | 116.33% | 22.01% |
| Cash from Investing | 102.59% | -660.45% | 364.61% | 109.11% | 17.49% |
| Total Debt Issued | -- | -100.00% | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 75.11% | 10,948.48% | -98.60% | 3,784.52% | -79.81% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 98.36% | -- | -- | -- | -- |
| Cash from Financing | 98.30% | 115.66% | -28.65% | 3,784.52% | -79.81% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 261.37% | 589.63% | -65.10% | 138.06% | -27.21% |